简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2024-01-19 13:22 Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer
2024-01-19 10:37 ELIQUENT Life Sciences Announces Acquisition of European-Focused Regulatory Partner: RApport Global Strategic Services
2024-01-19 10:33 Takeda Named Global Top Employer for Seventh Consecutive Year
2024-01-18 12:42 Timeline, a Swiss Longevity Biotech, Secures Pivotal Financing Round with Support from Strategic Global Industry Leaders, including L’Oréal and Nestlé
2024-01-17 14:24 TOXINS 2024: Galderma’s Phase III RelabotulinumtoxinA Results Demonstrate Positive Efficacy and Long Duration of Effect When Treating Frown Lines and Crow’s Feet Simultaneously
2024-01-17 11:26 Parse Biosciences Acquires Biomage
2024-01-17 11:22 Xenco Medical Unveils the TrabeculeX Continuum, a Breakthrough Convergence of Digital Health and Biomaterials, at CES 2024 in Las Vegas, the World’s Largest Technology Conference
2024-01-17 10:56 KBI Biopharma, Inc. and Argonaut Manufacturing Services, Inc. Forge Strategic Alliance to Support Global Biopharmaceutical Companies with Integrated Drug Substance and Drug Product Solutions
2024-01-17 09:03 Women's Health Remains in Crisis Worldwide Even as COVID-19 Pandemic Wanes
2024-01-17 09:01 U.S. FDA Approves Takeda’s HYQVIA® as Maintenance Therapy in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
2024-01-16 10:35 Neuraptive Therapeutics Inc. Receives Orphan Drug Designation for its Lead Development Asset
2024-01-12 12:29 ELIQUENT Life Sciences Announces Steve Purtell as Chief Financial Officer
2024-01-11 10:13 QPS Significantly Enhances Mass Spectrometry Laboratory Capacity
2024-01-11 09:10 Medidata Secures Top Honors in Everest Group's Decentralized Clinical Trial Platforms PEAK Matrix® Assessment
2024-01-11 09:03 Myrobalan Therapeutics Completes Series A Financing of $24 Million to Develop Potentially First-in-Class CNS Therapeutics with Restorative Potential
2024-01-10 10:15 World’s First Kidney Tumor Treated Using the HistoSonics’ Edison® Histotripsy System
2024-01-09 10:20 Neuraptive Therapeutics, Inc. Announces Achievement of Proof of Concept in The NEUROFUSE Study of NTX-001 for the Adjunct Treatment of Transected Peripheral Nerves
2024-01-09 10:15 Validant Group of Companies Unite as ELIQUENT Life Sciences
2024-01-09 09:51 ENYO Pharma Announces a €39 Million Series C Financing and FDA Clearance to Advance Vonafexor in a Phase 2 Clinical Trial for Patients With Alport Syndrome
2024-01-09 09:48 Biocytogen Enters into Bispecific Antibody Drug Conjugate Agreement with Radiance Biopharma

Business Wire Weibo

Press Releases

Latest Releases